NovoCure Ltd. (NVCR)
14.32
-0.08
(-0.56%)
USD |
NASDAQ |
Oct 27, 09:41
NovoCure Enterprise Value : 1.460B for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 1.460B |
| October 23, 2026 | 1.492B |
| October 22, 2026 | 1.541B |
| October 21, 2026 | 1.598B |
| October 20, 2026 | 1.612B |
| October 19, 2026 | 1.517B |
| October 16, 2026 | 1.421B |
| October 15, 2026 | 1.461B |
| October 14, 2026 | 1.395B |
| October 13, 2026 | 1.448B |
| October 12, 2026 | 1.497B |
| October 09, 2026 | 1.481B |
| October 08, 2026 | 1.439B |
| October 07, 2026 | 1.490B |
| October 06, 2026 | 1.526B |
| October 05, 2026 | 1.553B |
| October 02, 2026 | 1.523B |
| October 01, 2026 | 1.637B |
| September 30, 2026 | 1.640B |
| September 29, 2026 | 1.645B |
| September 28, 2026 | 1.626B |
| September 25, 2026 | 1.627B |
| September 24, 2026 | 1.669B |
| September 23, 2026 | 1.675B |
| September 22, 2026 | 1.724B |
| Date | Value |
|---|---|
| September 21, 2026 | 1.708B |
| September 18, 2026 | 1.726B |
| September 17, 2026 | 1.730B |
| September 16, 2026 | 1.672B |
| September 15, 2026 | 1.663B |
| September 14, 2026 | 1.672B |
| September 11, 2026 | 1.589B |
| September 10, 2026 | 1.570B |
| September 09, 2026 | 1.603B |
| September 08, 2026 | 1.745B |
| September 04, 2026 | 1.872B |
| September 03, 2026 | 1.837B |
| September 02, 2026 | 1.859B |
| September 01, 2026 | 1.807B |
| August 31, 2026 | 1.838B |
| August 28, 2026 | 1.858B |
| August 27, 2026 | 1.878B |
| August 26, 2026 | 1.866B |
| August 25, 2026 | 1.835B |
| August 24, 2026 | 1.735B |
| August 21, 2026 | 1.774B |
| August 20, 2026 | 1.852B |
| August 19, 2026 | 1.902B |
| August 18, 2026 | 1.790B |
| August 17, 2026 | 1.824B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LivaNova Plc | 4.274B |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
| Polarean Imaging Plc | -- |
| Accuray, Inc. | 161.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.66M |
| Revenue (Quarterly) | 183.58M |
| Total Expenses (Quarterly) | 199.24M |
| EPS Diluted (Quarterly) | -0.135 |
| Gross Profit Margin (Quarterly) | 77.61% |
| Profit Margin (Quarterly) | -8.53% |
| Earnings Yield | -9.14% |
| Normalized Earnings Yield | -9.145 |